William Blair Downgrades Bristol-Myers Squibb to Market Perform
Portfolio Pulse from Benzinga Newsdesk
William Blair analyst Matt Phipps has downgraded Bristol-Myers Squibb (NYSE:BMY) from Outperform to Market Perform.
October 27, 2023 | 10:39 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bristol-Myers Squibb has been downgraded by William Blair from Outperform to Market Perform.
The downgrade by William Blair from Outperform to Market Perform indicates a less optimistic outlook for Bristol-Myers Squibb. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100